Laser Therapy Shows Promise for Hard-to-Treat Epilepsy
Source: Frontiers in surgery
Summary
What was studied
This paper was a review of reviews. The authors looked at 16 systematic reviews about MRI-guided laser interstitial thermal therapy (MRgLITT) for people with drug-resistant epilepsy, meaning seizures that did not respond well to medicine.
The reviews they included were based only on observational studies, such as cohort studies and case series. The most common cause of drug-resistant epilepsy discussed was mesial temporal lobe epilepsy. The authors searched several major medical databases through May 30, 2024, and judged how trustworthy the reviews were.
What they found
Across the reviews, the reported seizure freedom rate after MRgLITT ranged widely, from about 19% to 76%. The most commonly reported complications were visual field problems, reported in about 2.17% to 7.5% of patients, and bleeding inside the skull, reported in about 0.96% to 8.6%.
The overall quality of the evidence was poor. Fourteen of the 16 reviews were rated "critically low" quality, and all main outcomes were judged to have "very low" certainty. In simple terms, MRgLITT appears promising, but the current research does not allow firm conclusions about how well it works or how safe it is.
Limits of the evidence
This study does not show that MRgLITT works better than other epilepsy treatments. It reviewed earlier reviews, and those reviews were based only on observational studies, not randomized trials.
The results varied a lot between reviews, especially for seizure freedom. Because the evidence certainty was rated very low, the true benefits and risks could be different from the reported numbers.
For families and caregivers
For families considering epilepsy surgery or less invasive procedures, this review suggests that MRgLITT may help some people become seizure-free. It also shows that complications can happen, including vision-related problems and bleeding.
The main takeaway is that MRgLITT is a developing option, but the evidence is still uncertain. Families may want to ask what is known about likely benefits, possible risks, and how strong the evidence is for their specific epilepsy type.
What to watch next
Further primary and secondary studies are needed to better assess seizure outcomes, complications, and the potential role of MRgLITT in future clinical recommendations.
Terms in this summary
- MRI-guided laser interstitial thermal therapy (MRgLITT)
- A procedure that uses a laser, guided by MRI scans, to heat and destroy a small area of brain tissue linked to seizures.
- drug-resistant epilepsy
- Epilepsy in which seizures continue despite trying appropriate seizure medicines.
- systematic review
- A study that collects and summarizes results from many earlier studies using a planned method.
- observational study
- A study where researchers observe what happens in patients receiving care, without randomly assigning treatments.
- case series
- A report describing outcomes in a group of patients who received the same treatment, without a comparison group.
- seizure freedom
- Having no seizures during the follow-up period measured in a study.
- mesial temporal lobe epilepsy
- A type of epilepsy involving deep structures of the temporal lobe.
- certainty of evidence
- How confident researchers are that the study results are close to the truth.
Free: Seizure First Aid Quick Guide (PDF)
Plus one plain-language weekly digest of new epilepsy research.
Unsubscribe anytime. No medical advice.